Clinical Trials Logo

Tricuspid Valve Disease clinical trials

View clinical trials related to Tricuspid Valve Disease.

Filter by:

NCT ID: NCT04665583 Terminated - Clinical trials for Tricuspid Regurgitation

Prehab Prior to Undergoing Tricuspid Intervention

Start date: October 25, 2020
Phase:
Study type: Observational

This study will aim to standardize the prehabilitation protocol to optimize patients and document the clinical and echo variables that could improve clinical outcomes of tricuspid valve intervention.

NCT ID: NCT04482062 Recruiting - Heart Failure Clinical Trials

TRISCEND II Pivotal Trial

Start date: April 9, 2021
Phase: N/A
Study type: Interventional

Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system

NCT ID: NCT04231461 Recruiting - Clinical trials for Aortic Valve Stenosis

Quality of Life After Cardiac Surgery

QUACS
Start date: July 19, 2019
Phase:
Study type: Observational

During the last twenty years heart surgery has become safer and the number of patients having heart surgery has increased with more frail patients being offered increasingly complex surgery. Heart operations often improve survival and quality of life (QoL), but that is not true for all patients. Regarding survival, clinicians can measure the risk to life from having a heart operation and the risk to life from not quite precisely, but clinicians have little idea about the impact of heart operations on QoL, which is the outcome that patients care about most. Clinicians are unable to provide patients with robust information on how an operation will affect their QoL. This study will provide this information by analysing the data from patient questionnaires immediately before and after the procedure and monthly thereafter for 12 months.

NCT ID: NCT04097145 Recruiting - Clinical trials for Tricuspid Regurgitation

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

CLASP II TR
Start date: December 11, 2019
Phase: N/A
Study type: Interventional

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

NCT ID: NCT03859102 Recruiting - Clinical trials for Coronary Artery Disease

Enhanced Recovery After Cardiac Surgery

ERAS
Start date: December 17, 2018
Phase: N/A
Study type: Interventional

Enhanced Recovery Protocols (ERPs or bundles) have been established in many surgical specialties (such as colon cancer and orthopaedic joint surgeries) for several years in hospitals worldwide. The principles of Enhanced Recovery Protocols are those of early mobilization and restoration of normal function as soon as possible after surgery. These principles are achieved by use of alternate pain control regimens and removing invasive lines and drains as soon as possible. The benefits of ERPs are improved patient experience, earlier return to normal function and reduced length of stay. Enhanced recovery protocols for cardiac surgery have been published by the Enhanced Recovery After Cardiac Surgery Society. The current study will investigate whether it is possible to utilise ERP bundles in the population of cardiac surgery patients at James Cook Hospital, with a view to rolling out a full ERP service. Secondary study outcomes will be patient-centred, including; pain scores, nausea and vomiting rates and time taken to return to normal function.

NCT ID: NCT03546231 Recruiting - Clinical trials for Tricuspid Valve Disease

Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation

EPIT
Start date: March 2, 2018
Phase:
Study type: Observational

The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.

NCT ID: NCT03239262 Completed - Clinical trials for Coronary Artery Disease

Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation

Start date: July 1, 2012
Phase: N/A
Study type: Interventional

The aim of our study was to investigate, whether enhancement of left atrial cryoablation by ablation of the autonomic nervous system of left atrium leads to influencing the outcomes of surgical treatment of atrial fibrillation in patients with structural heart disease undergoing open-heart surgery.

NCT ID: NCT02397668 Recruiting - Clinical trials for Tricuspid Valve Disease

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The Pivotal Study of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve). This study follows the EFS and is now to determine the safety and efficacy of the Cormatrix Cor TRICUSPID Valve for any patients requiring surgical replacement of the tricuspid valve.